NOVO NORDISK
Oral Semaglutide – Convention Booth Engagement Concepts

Novo Nordisk was in the process of launching a new oral delivery drug to help treat diabetes. Our team created a comprehensive design campaign to bring awareness to the new drug at AACC in Washington, DC. Embracing the idea that this new oral delivery drug brings new opportunities to those living with diabetes, we developed a visual identity that evoked the emotions felt at the start of a new day with new opportunities. The campaign featured before and after promotional communications, website landing pages, signage around the event venue, in suite communications and even speciality catered menus for attendees.